Prevalence of infections in intensive care units in Mexico: A multicenter study

Critical Care Medicine

Volumn 28, Issue 5, 2000, Pages 1316-1321

  De León Rosales, Samuel Ponce ^a   Molinar Ramos, Fernando ^b   Domínguez Cherit, Guillermo ^a   Rangel Frausto, M Sigfrido ^a   Vázquez Ramos, Victoria G ^c  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b Intensive Care Unit   (Mexico)

^c Medical Oncology Department   (Mexico)

Author keywords

Bacteremia; Intensive care unit; Mortality rates; Nosocomial infection; Risk factor; Sepsis

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BACTEREMIA; FEMALE; HOSPITAL INFECTION; HUMAN; HYPEROSMOLALITY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEXICO; MORTALITY; NEUROLOGIC DISEASE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINARY TRACT INFECTION; WOUND INFECTION;

EID: 0034106443     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200005000-00010     Document Type: Article

References (19)

1. 1. Calvin JE: Balancing cost considerations and quality of care. In: Critical Care Medicine: Principles, Diagnosis and Management. Parrillo JE (Ed). St Louis, MO, CV Mosby, 1995, pp. 1431-1445
2. 2. Vincent JL, Bihari DJ, Suter PM, et al: The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995; 274: 639-644
3. 3. Craven DE, Kunches LM, Lichtenberg DA, et al: Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 1988; 148:1161-1168
4. 4. Wenzel RP, Thompson RL, Landry SM, et al: Hospital-acquired infections in intensive care unit patients: An overview with emphasis on epidemics. Infect Control 1983; 4:371-375
5. 5. Haley RW, Culver DH, White JW, et al: The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985; 121:182-205
6. 6. Ponce de León RS: Infecciones hospitalarias en México. In: Desarrollo y Fortalecimiento de los Sistemas Locales de Salud: La Garantía de Calidad; Acreditación de Hospitales para América Latina y el Caribe. Paganini JM, Moraes HN (Eds). Washington, DC, OPS, 1992, pp 178-186
7. 7. Parker RL: Los Hospitales de México. México City, México, PC Editores, 1994, pp 1-536
8. 8. Ponce de León S, García GM, Volkow FP: Resultados iniciales de un programa de vigilancia de infecciones nosocomiales en los institutes nacionales de salud. Sal Pub Mex 1986; 28:111-222
9. 9. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1988; 13: 818-829
10. 10. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP/SCCM Consensus Conference Committee; American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
11. 11. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128-140
12. 12. Perl TM: Surveillance, reporting and the use of computers. In: Prevention and Control of Nosocomial Infections. Second Edition. Wenzel RP (Ed). Baltimore: Williams & Wilkins, 1993, pp. 139-176
13. 13. Weinstein RA: Epidemiology and control ofnosocomial infections in adult intensive care units. Am J Med 1991; 91:1798-1848
14. 14. Verbist L: Epidemiology and sensitivity of 8625 ICU hematology/oncology bacterial isolates in Europe. Scand J Infect Dis 1993; 91(Suppl):14-24
15. 15. Banerjee SN, Emori TG, Culver DH, et al: Secular trends in nosocomial primary blood-stream infections in the United States, 1980-1989: National Nosocomial Infections Surveillance System. Am J Med 1991; 91: 86S-89S
16. 16. Tryba M: Sucralfate versus antacids or H2-antagonsits for stress ulcer prophylaxis: A meta-analysis on efficacy and pneumonia rate. Crit Care Med 1991; 19:942-949
17. 17. Lorian V: The need for surveillance for antimicrobial resistance. Infect Control Hosp Epidemiol 1995; 6:11, 638-641
18. 18. Pittet D, Thiévent B, Wenzel RP, et al: Bedside prediction of mortality from bacteremic sepsis: A dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996; 153: 684-693
19. 19. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS). JAMA 1995; 273:117-123